Lumira DX is a global healthcare company that specializes in providing high sensitivity point-of-care diagnostic systems. Their innovative LumiraDx Platform combines a portable instrument, microfluidic test strip, and seamless digital connectivity to deliver lab-comparable performance and real-time results at the point of care. With a broad test menu and improved economic value, Lumira DX aims to strengthen community-based healthcare and make affordable diagnostics accessible to healthcare providers worldwide.
Lumira DX's cutting-edge technology offers a range of assay capabilities, including COVID-19 antigen and antibody tests, as well as over 30 other tests across various assay technologies. Their cloud-based platform empowers healthcare professionals with effortless data reporting, analytics, and decision support, making it suitable for emergency departments, primary care, health clinics, and retail pharmacies. With a focus on better health experiences, outcomes, and cost control, Lumira DX is committed to supporting healthier lives for individuals, communities, and society as a whole.
Generated from the website